QA: Abbvie Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001551152_2025_Abbvie_Inc.pdf

Logs

Graph

Absolute values for 0001551152, Abbvie Inc

  xvar xval
0 AssetsCurrent 25,582,000,000
1 IntangibleAssetsNetIncludingGoodwill 95,024,000,000
2 PropertyPlantAndEquipmentNet 5,134,000,000
3 remainder_Assets 9,421,000,000
4 LiabilitiesCurrent 38,749,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 16,870,244,252
8 SellingGeneralAndAdministrativeExpense 14,867,135,902
9 ResearchAndDevelopmentExpense 14,410,574,755
10 remainder_Expenses -443,481,738
11 remainder_Revenues 57,148,763,921
12 remainder_NetIncome -5,496,741,550
13 remainder_ComprehensiveNetIncome 175,100,678
  yvar yval
0 Assets 135,161,000,000
1 Liabilities 38,749,000,000
2 Expenses 45,704,473,171
3 Revenues 57,148,763,921
4 StockholdersEquity 96,412,000,000
5 NetIncome 5,947,549,200
6 ComprehensiveNetIncome 6,035,099,539
7 BaseVar 141,217,539,660
8 EconomicCapitalRatiobeforeLimitedLiability 2.49
9 EconomicCapitalRatio 3.35

Edgar->Model Mapping

Feature Distribution

Change over Time